Lymphoma Research Foundation (LRF): Diffuse Large B Cell Lymphoma (DLBCL) Research Initiative

$250K over 2 years to investigate the pathogenesis, diagnosis or treatment of DLBCL. Proposals should include a clear indication of how the project is clinically relevant to the improvement of outcomes for patients with DLBCL.

Applications to all the initiatives above must include the study of primary FL/DLBCL/CLL/MBL patient samples to assure relevance to the human disease, and, the proposed studies should incorporate collaborative interactions between/among investigators in different disciplines (e.g. pathology & medical oncology, basic science research & clinical investigators) and/or different institutions. LRF intends to fund up to 2 applications in each of the programs.

http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6330663